Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Lorus Therapeutics Inc. · Toronto, ON Canada ·(NYSE Alternext: LRP)(Toronto: LOR)

Company Description

2 Meridian Rd.
Toronto, ON
M9W 4-Z7
Canada (Map)
Phone: +1-416-7981200
Fax: +1-416-7982200
    View Lorus Therapeutics Inc. Locations On A US MapThis link will open in a new window
    Lorus Therapeutics isn't talking nonsense, they're talking antisense. The biotechnology firm is developing cancer drugs using antisense technology, which prevents cells from producing disease-causing proteins and may cause fewer side effects than traditional chemotherapies. It is testing its lead candidate in this area, LOR-2040, as a treatment for various blood cancers and solid tumors. Lorus is working in other areas of cancer research as well, developing some traditional therapies, as well as immunotherapies, which stimulate the body's immune system to fight cancer. The company licensed its Virulizin immunotherapy, a potential treatment for pancreatic cancer, to a subsidiary of Zoticon Bioventures in 2008. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Lorus Therapeutics Inc. Financials

    Company TypePublic - NYSE Alternext: LRP - Toronto: LOR

    Headquarters
    Fiscal Year-EndMay
    2009 Sales (mil.)$0.2
    2008 Employees26

    Lorus Therapeutics Inc. Executives

    9 executives listed for Lorus Therapeutics Inc.'s Toronto, ON location.
    TitleName & BioContact
    ChairmanDennis BurgerNetwork
    Director, President and CEOAiping YoungNetwork
    Director Finance and Acting CFOElizabeth WilliamsNetwork

    Competition

    Competitive Landscape for Lorus Therapeutics Inc.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Lorus Therapeutics Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!